Creative Planning T2 Biosystems, Inc. Transaction History

Creative Planning

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$0.09 - $565.0 $103 - $649,750	-1,150 Reduced 5.52%	19,668 $2,000
Q2 2022 Aug 15, 2022	BUY	$0.15 - $0.54 $1,440 - $5,186	9,604 Added 85.64%	20,818 $3,000
Q1 2022 May 16, 2022	BUY	$0.36 - $0.57 $414 - $655	1,150 Added 11.43%	11,214 $6,000
Q4 2021 Feb 11, 2022	SELL	$0.46 - $0.94 $13,662 - $27,918	-29,700 Reduced 74.69%	10,064 $5,000
Q3 2021 Nov 10, 2021	BUY	$0.86 - $1.21 $688 - $968	800 Added 2.05%	39,764 $36,000
Q2 2021 Aug 04, 2021	BUY	$1.04 - $1.69 $15,319 - $24,893	14,730 Added 60.78%	38,964 $46,000
Q1 2021 Apr 30, 2021	BUY	$1.32 - $3.79 $5,676 - $16,297	4,300 Added 21.57%	24,234 $39,000
Q4 2020 Jan 29, 2021	BUY	$1.06 - $1.51 $6,078 - $8,658	5,734 Added 40.38%	19,934 $25,000
Q2 2020 Jul 23, 2020	SELL	$0.48 - $1.67 $11,232 - $39,078	-23,400 Reduced 62.23%	14,200 $18,000
Q1 2020 May 05, 2020	BUY	$0.28 - $1.23 $6,608 - $29,028	23,600 Added 168.57%	37,600 $24,000
Q4 2019 Jan 30, 2020	SELL	$0.96 - $2.94 $2,880 - $8,820	-3,000 Reduced 17.65%	14,000 $16,000
Q3 2019 Nov 01, 2019	BUY	$0.58 - $3.01 $9,860 - $51,170	17,000 New	17,000 $43,000
Q2 2019 Jul 26, 2019	SELL	$1.47 - $3.16 $16,464 - $35,392	-11,200 Closed	0 $0
Q1 2019 Apr 24, 2019	SELL	$2.56 - $4.48 $20,480 - $35,840	-8,000 Reduced 41.67%	11,200 $29,000
Q4 2018 Feb 01, 2019	BUY	$2.98 - $6.86 $12,516 - $28,812	4,200 Added 28.0%	19,200 $58,000
Q3 2018 Oct 25, 2018	BUY	$5.36 - $7.83 $80,400 - $117,450	15,000 New	15,000 $112,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.